TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 1079-1092

  Gressner, Axel M ^a   Lahme, Birgit ^a   Mannherz, Hans Georg ^b   Polzar, Bernard ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c NONE

Author keywords

Apoptosis; Hepatocytes; Hepatoma cells; TGF

Indexed keywords

ALKALINE PHOSPHATASE; HOE 33342; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER CELL CULTURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LATENT PERIOD; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

EID: 0030982229     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80117-1     Document Type: Article

References (70)

1. Lawrence DA. Transforming growth factor-beta: an overview. Kidney Int. 47:1995;19-23.
2. Massague J, Cheifetz S, Laiho M, Ralph DA, Weis FMB. Transforming growth factor-beta. Cancer Surv. 12:1992;81-103.
3. Bedossa P, Paradis V. Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis. J Hepatol. 22:1995;37-42.
4. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA. 92:1995;2572-2576.
5. Border WA, Noble NA. Mechanisms of disease: transforming growth factor-beta in tissue fibrosis. N Engl J Med. 331:1994;1286-1292.
6. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N. Transforming growth factor-beta mRNA increases during liver regeneration. A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA. 85:1988;1539-1543.
7. Michalopoulos GK. Liver regeneration: molecular mechanisms of growth control. FASEB J. 4:1990;176-187.
8. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J. 9:1995;1277-1287.
9. Alison MR, Sarraf CE. Liver cell death - patterns and mechanisms. Gut. 35:1994;577-581.
10. Buja LM, Eigenbrodt ML, Eigenbrodt EH. Apoptosis and necrosis - basic types and mechanisms of cell death. Arch Pathol Lab Med. 117:1993;1208-1214.
11. Benedetti A, Disario A, Baroni GS, Jezequel AM. Transforming growth factor (beta 1) increases the number of apoptotic bodies and decreases intracellular pH in isolated periportal and perivenular rat hepatocytes. Hepatology. 22:1995;1488-1498.
12. Bursch W, Oberhammer F, Jirtle RL, Askari M, Sedivy R, Grasl-Kraupp B, Purchio AF, Schulte-Hermann R. Transforming growth factor-beta1 as a signal for induction of cell death by apoptosis. Br J Cancer. 67:1993;531-536.
13. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, Schulte-Hermann R. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res. 51:1991;2478-2485.
14. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-betal. Proc Natl Acad Sci USA. 89:1992;5408-5412.
15. Hully JR, Chang L, Schwall RH, Widmer HR, Terrell TG, Gillett NA. Induction of apoptosis in the murine liver with recombinant human activin A. Hepatology. 20:1994;854-861.
16. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG. Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology. 18:1993;347-356.
17. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 21:1995;1465-1468.
18. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
19. Gressner AM, Polzar B, Lahme B, Mannherz HG. Induction of rat liver parenchymal cell apoptosis by hepatic myofibroblasts via transforming growth factor beta. Hepatology. 23:1996;571-581.
20. Fesus L, Davies PJA, Piacentini M, Apoptosis: molecular, mechanisms in programmed cell death. Eur J Cell Biol. 56:1991;170-177.
21. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta1 (TGF-beta1) and TGF-beta1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 21:1995;760-766.
22. Ito N, Kawata S, Tamura S, Takaishi K, Shirai Y, Kiso S, Yabuuchi I, Matsuda Y, Nishioka M, Tarui S. Elevated levels of transforming growth factor-beta messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res. 51:1991;4080-4083.
23. Bissell DM, Wang SS, Jarnagin WR, Roll FJ. Cell-specific expression of transforming growth factor-beta in rat liver - evidence for autocrine regulation of hepatocyte proliferation. J Clin Invest. 96:1995;447-455.
24. Chunfang Gao, Gressner G, Zoremba M, Gressner AM. Transforming growth factor-beta (TGF-beta) expression in isolated and cultured rat hepatocytes. J Cell Physiol. 167:1996;394-405.
25. Enzan H, Himeno H, Iwamura S, Saibara T, Yamamoto Y, Hara H. Alpha-Smooth muscle actin-positive perisinusoidal stromal cells in human hepatocellular carcinoma. Hepatology. 19:1994;895-903.
26. Gressner AM, Lahme B. Treatment of rat hepatocytes with transforming growth factor-beta1 increases their mitogenic activity for cultured fat storing cells. Int Hepatol Commun. 4:1995;94-101.
27. Seglen PO. Preparation of isolated rat liver cells. Prescott DM. Methods in Cell Biology. 8:1987;29-83 Academic Press, New York.
28. Gressner AM, Pfeiffer T. Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulfate synthesis in hepatocytes. J Clin Chem Clin Biochem. 24:1986;821-829.
29. Deschatrette J, Weiss MC. Characterization of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie. 56:1974;1603-1611.
30. Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 209:1980;497-499.
31. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
32. Brown PD, Wakefield LM, Levinson AD, Sporn MB. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors. 3:1990;35-43.
33. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter luciferase construct. Anal Biochem. 216:1994;276-284.
34. Bachem MG, Meyer DM, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblast-like cells - a potential mechanism of self-perpetuation in liver fibrogenesis. J Clin Invest. 89:1992;19-27.
35. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein HA, Manson DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP) complexes. J Histochem Cytochem. 32:1984;219-229.
36. Wijsman JH, Jonker RR, Keijzer R, Velde van de CJH, Cornelisse CJ, Dierendonck van JH. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem. 41:1993;7-12.
37. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 102:1980;344-352.
38. Zvibel I, Halay E, Reid LM. Heparin and hormonal regulation of mRNA synthesis and abundance of autocrine growth factors: relevance to clonal growth of tumors. Mol Cell Biol. 11:1991;108-116.
39. Kraft A, Reid LM, Zvibel I. Suramin inhibits growth and yet promotes insulin-like growth factor II expression in HepG2 cells. Cancer Res. 53:1993;652-657.
40. Oberhammer F, Bursch W, Tiefenbacher R, Fröschl G, Pavelka M, Purchio T, Schulte-Hermann R. Apoptosis is induced by transforming growth factor-beta1 within 5 hours in regressing liver without significant fragmentation of the DNA. Hepatology. 18:1993;1238-1246.
41. Oberhammer F, Nagy P, Tiefenbacher R, Fröschl G, Bouzahzah B, Thorgeirsson SS, Carr B. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor-beta1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. Hepatology. 23:1996;329-337.
42. LaMarre J, Vasudevan J, Gonias SL. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface. Biochem J. 302:1994;199-205.
43. Lyons RM, Keski-Oja J, Moses HL. Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J Cell Biol. 106:1988;1659-1665.
44. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanisms of activation of latent recombinant transforming growth factor beta-1 by plasmin. J Cell Biol. 110:1990;1361-1367.
45. Schultz-Cherry S, Murphy-Ullrich JE. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol. 122:1993;923-932.
46. Schultz-Cherry S, Lawler J, Murphy-Ullrich JE. The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta. J Biol Chem. 269:1994;26783-26788.
47. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA. 88:1991;580-584.
48. Debleser PJ, Jannes P, Buul-Offers van SC, Hoogerbrugge CM, Schravendijk van CFH, Niki T, Rogiers V, Brande van den JL, Wisse E, Geerts A. Insulin-like growth factor-II/mannose 6-phosphate receptor is expressed on CCl4-exposed rat fat-storing cells and facilitates activation of latent transforming growth factor-beta in cocultures with sinusoidal endothelial cells. Hepatology. 21:1995;1429-1437.
49. Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 316:1985;701-705.
50. Kalkhoven E, Roelen BAJ, Dewinter JP, Mummery CL, Vandeneijndenvanraaij AJM, Vandersaag PT, Vanderburg B. Resistance to transforming growth factor beta and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Differ. 6:1995;1151-1161.
51. Ito N, Kawata S, Tamura S, Takaishi K, Saitoh R, Tarui S. Modulation of c-myc expression by transforming growth factor-beta1 in human hepatoma cell lines. Jpn J Cancer Res. 81:1990;216-219.
52. Chuang LY, Hung WC, Chang CC, Tsai JH. Characterization of apoptosis induced by transforming growth factor beta1 in human hepatoma cells. Anticancer Res. 14:1994;147-152.
53. Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res. 52:1992;385-388.
54. Inagaki M, Moustakas A, Lin HY, Lodish HF, Carr BI. Growth inhibition by transforming growth factor-beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. Proc Natl Acad Sci USA. 90:1993;5359-5363.
55. Fukuda K, Kojiro M, Chiu JF. Induction of apoptosis by transforming growth factor-beta1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology. 18:1993;945-953.
56. Yamamoto M, Ogawa K, Morita M, Fukuda K, Komatsu Y. The herbal medicine inchio-ko-to inhibits liver cell apoptosis induced by transforming growth factor-beta1. Hepatology. 23:1996;552-559.
57. Takaishi K, Kawata S, Ito N, Tamura S, Shirai Y, Tarui S. Effects of phorbol ester on cell growth inhibition by transforming growth factor-beta1 in human hepatoma cell lines. Biochem Biophys Res Commun. 171:1990;91-96.
58. McMahon JB, Richards WL, Campo del AA, Song MKH, Thorgeirsson SS. Differential effects of transforming growth factor-beta on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res. 46:1986;4665-4671.
59. Huggett AC, Hampton LL, Ford CP, Wirth PJ, Thorgeirsson SS. Altered responsiveness of rat liver epithelial cells to transforming growth factor-beta1 following their transformation with v-raf. Cancer Res. 50:1990;7468-7475.
60. Huggett AC, Ellis PA, Ford CP, Hampton LL, Rimoldi D, Thorgeirsson SS. Development of resistance to the growth inhibitory effects of transforming growth factor beta1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res. 51:1991;5929-5936.
61. Wollenberg GK, Semple E, Quinn BA, Hayes MA. Inhibition of proliferation of normal, preneoplastic, and neoplastic rat hepatocytes by transforming growth factor-beta1. Cancer Res. 47:1987;6595-6599.
62. Altman DJ, Schneider SL, Thompson DA, Cheng HL, Tomasi TB. A transforming growth factor-beta2 (TGF-beta2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta2 mRNA in the pregnant uterus. J Exp Med. 172:1990;1391-1401.
63. LaMarre J, Wollenberg GK, Gauldie J, Hayes MA. Alpha-macroglobulin and serum preferentially counteract the mito-inhibitory effect of transforming growth factor-beta2 in rat hepatocytes. Lab Invest. 62:1990;545-551.
64. LaMarre J, Wollenberg GK, Gonias SL, Hayes MA. Biology of disease: cytokine binding and clearance properties of proteinase-activated alpha2-macroglobulins. Lab Invest. 65:1991;3-14.
65. Bauer G. Resistance to TGF-beta-induced elimination of transformed cells is required during tumor progression (review-hypothesis). Intern J Oncol. 6:1995;1227-1229.
66. Friedman SL. The cellular basis of hepatic fibrosis. N Engl J Med. 328:1993;1828-1835.
67. Gressner AM. Activation of proteoglycan synthesis in injured liver - a brief review of molecular and cellular aspects. Eur J Clin Chem Clin Biochem. 32:1994;225-237.
68. Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion. 56:1995;335-346.
69. Orning U, Schuppan D, Pemecky K, Dienes HP, Schirmacher P. Extracellular matrix proteins in hepatocellular carcinoma. Hepatology. 22:1995;324A.
70. Suzuki T, Kuramitsu K, Kuribayashi N, Takamatsu S, Kojiro M, Matsuura Y, Miyamura T, Miyamoto H. Apoptosis of hepatocytes highly correlates with liver fibrosis in chronic hepatitis B. Hepatology. 22:1995;267A.